These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 25000539)

  • 1. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatically cross-linked hyaluronic acid/graphene oxide nanocomposite hydrogel with pH-responsive release.
    Song F; Hu W; Xiao L; Cao Z; Li X; Zhang C; Liao L; Liu L
    J Biomater Sci Polym Ed; 2015; 26(6):339-52. PubMed ID: 25598448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
    Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
    Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
    Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
    Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
    Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
    Datir SR; Das M; Singh RP; Jain S
    Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
    Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging.
    Gao Y; Zou X; Zhao JX; Li Y; Su X
    Colloids Surf B Biointerfaces; 2013 Dec; 112():128-33. PubMed ID: 23973670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
    Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y
    Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
    Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
    Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
    Kundu A; Nandi S; Das P; Nandi AK
    ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
    Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery.
    Nahain AA; Lee JE; Jeong JH; Park SY
    Biomacromolecules; 2013 Nov; 14(11):4082-90. PubMed ID: 24106989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.